Longitudinal trajectory of cancer-related cognitive impairment up to six-months post-chemotherapy: A nationwide NCORP study in 839 breast cancer patients and non-cancer controls.
Michelle C. Janelsins(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Tim A. Ahles(Memorial Sloan Kettering Cancer Center), Luke J. Peppone(University of Rochester Medical Center), Supriya G. Mohile(University of Rochester Medical Center), Charles Kamen(University of Rochester), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Lora Weiselberg(Seagen (Canada)), Allison Magnuson(University of Rochester Medical Center), Ian R. Kleckner(University of Maryland, College Park), Jerry W. Mitchell(Seagen (Canada)), Alison Conlin(Providence Portland Medical Center), K. Young(Duke Medical Center)
Cited by 0
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
|Journal of Clinical Oncology|2020|556
Applied Discriminant Analysis
|Technometrics|1995|409